{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Normal+saline+solution&page=83", "query": { "intervention": "Normal saline solution", "page": 83 }, "page_size": 10 }, "pagination": { "page": 83, "page_size": 10, "total_count": 2691, "total_pages": 270, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Normal+saline+solution&page=84&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Normal+saline+solution&page=82&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-06T14:14:58.030Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04112160", "title": "Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pain", "Urinary Stone", "Urinary Calculi" ], "interventions": [ { "name": "Ketorolac", "type": "DRUG" }, { "name": "normal saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 125, "start_date": "2018-06-28", "completion_date": "2019-08-30", "has_results": true, "last_update_posted_date": "2024-01-10", "last_synced_at": "2026-11-06T14:14:58.030Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04112160" }, { "nct_id": "NCT00138424", "title": "Cidofovir in Renal Transplant Recipients With BKVN", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "BK Virus (Nephropathy)" ], "interventions": [ { "name": "Cidofovir", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2006-05", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2013-03-08", "last_synced_at": "2026-11-06T14:14:58.030Z", "location_count": 12, "location_summary": "Birmingham, Alabama • San Francisco, California • Aurora, Colorado + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00138424" }, { "nct_id": "NCT01494259", "title": "Bupivacaine Pain Pumps to Decrease Mastectomy Post-Operative Pain", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Bupivacaine", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "FEMALE", "summary": "18 Years to 100 Years · Female only" }, "enrollment_count": 0, "start_date": "2016-01", "completion_date": "2017-09", "has_results": false, "last_update_posted_date": "2015-10-14", "last_synced_at": "2026-11-06T14:14:58.030Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01494259" }, { "nct_id": "NCT04590586", "title": "Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Standard of care", "type": "DRUG" }, { "name": "Apremilast", "type": "DRUG" }, { "name": "Apremilast placebo", "type": "DRUG" }, { "name": "Lanadelumab", "type": "DRUG" }, { "name": "Lanadelumab placebo", "type": "DRUG" }, { "name": "Zilucoplan", "type": "DRUG" }, { "name": "Zilucoplan placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 515, "start_date": "2020-11-24", "completion_date": "2021-08-03", "has_results": true, "last_update_posted_date": "2022-06-29", "last_synced_at": "2026-11-06T14:14:58.030Z", "location_count": 21, "location_summary": "Anniston, Alabama • Bakersfield, California • Chula Vista, California + 17 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "El Centro", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04590586" }, { "nct_id": "NCT00583466", "title": "Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Large Polyps in the Gastrointestinal Tract" ], "interventions": [ { "name": "Autologous blood injection", "type": "DRUG" }, { "name": "Normal saline", "type": "DRUG" }, { "name": "HPMC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 18, "start_date": "2007-05", "completion_date": "2008-05", "has_results": true, "last_update_posted_date": "2017-09-13", "last_synced_at": "2026-11-06T14:14:58.030Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00583466" }, { "nct_id": "NCT02432456", "title": "Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Wounds and Injuries", "Rib Fractures" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Intercostal Nerve Block", "type": "PROCEDURE" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Pantoprazole", "type": "DRUG" }, { "name": "Methocarbamol", "type": "DRUG" }, { "name": "Opioid", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Medical College of Wisconsin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 153, "start_date": "2015-09", "completion_date": "2018-08", "has_results": true, "last_update_posted_date": "2020-02-05", "last_synced_at": "2026-11-06T14:14:58.030Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02432456" }, { "nct_id": "NCT00606905", "title": "Intravenous Immunoglobulin (IVIG) for Treatment of Unexplained Secondary Recurrent Miscarriage", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Miscarriage, Recurrent", "Abortion, Habitual" ], "interventions": [ { "name": "Gamimune N or Gamunex 10%", "type": "BIOLOGICAL" }, { "name": "normal saline", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 82, "start_date": "1999-11", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2012-10-08", "last_synced_at": "2026-11-06T14:14:58.030Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00606905" }, { "nct_id": "NCT02461641", "title": "NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Foot Ulcer, Diabetic" ], "interventions": [ { "name": "NuShield", "type": "OTHER" }, { "name": "Affinity", "type": "OTHER" }, { "name": "Standard of Care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "NuTech Medical, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 96, "start_date": "2015-03", "completion_date": "2018-10-25", "has_results": false, "last_update_posted_date": "2019-02-22", "last_synced_at": "2026-11-06T14:14:58.030Z", "location_count": 7, "location_summary": "Fresno, California • Indianapolis, Indiana • Opelousas, Louisiana + 4 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Opelousas", "state": "Louisiana" }, { "city": "Dunmore", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02461641" }, { "nct_id": "NCT03752905", "title": "A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Recessive Dystrophic Epidermolysis Bullosa" ], "interventions": [ { "name": "PTR-01", "type": "DRUG" }, { "name": "Normal saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Phoenix Tissue Repair, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 12, "start_date": "2019-01-09", "completion_date": "2020-11-30", "has_results": false, "last_update_posted_date": "2021-03-09", "last_synced_at": "2026-11-06T14:14:58.030Z", "location_count": 3, "location_summary": "Redwood City, California • Aurora, Colorado • Philadelphia, Pennsylvania", "locations": [ { "city": "Redwood City", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03752905" }, { "nct_id": "NCT00599131", "title": "Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cancer of Larynx" ], "interventions": [ { "name": "Cisplatin", "type": "DRUG" }, { "name": "Cetuximab", "type": "DRUG" }, { "name": "5-Fluorouracil", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan Rogel Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2007-08", "completion_date": "2010-10", "has_results": true, "last_update_posted_date": "2015-12-03", "last_synced_at": "2026-11-06T14:14:58.030Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00599131" } ] }